< Back to search
Filter
1

GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV

for
HIV, Alcohol, Smoking Cigarette,
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 18 - 70+

Code: NCT07221214

Phase2, Recruiting

Impact of Morning Light Therapy in IBD

for
Inflammatory Bowel Disease
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07207200

Recruiting

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

for
Inflammatory Bowel Disease
Location: Ann Arbor MI
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT07210580

Recruiting

Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

for
Graves Disease, Graves' Disease, Hyperthyroidism
Location: New Hyde Park NY
Sponsor: Northwell Health

Sex: All

Age: 9 - 17

Code: NCT07369063

Phase2, Recruiting

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

for
Graves Disease
Location: Boston MA, Philadelphia PA, Morehead City NC,
Sponsor: Merida Biosciences

Sex: All

Age: 18 - 65

Code: NCT07305818

Phase1, Recruiting

Interested in new autoimmune diseases trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

for
Inflammatory Bowel Disease (IBD), Crohn Disease (CD),
Location: Fredericton, Montreal, Oshawa, Toronto, Oakville,
Sponsor: TIDHI Innovation Inc.

Sex: All

Age: 18+

Code: NCT07245394

Recruiting

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

for
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 2 - 70+

Code: NCT07202598

Phase2, Recruiting

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

for
IBD, Crohn Disease (CD), Ulcerative Colitis (UC),
Location: Hartford CT
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 10 - 21

Code: NCT07224113

Recruiting

Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

for
Inflammatory Bowel Disease, Crohn Disease
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 13 - 20

Code: NCT04508088

Recruiting

A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

for
Lynch Syndrome, Crohn Disease, Inflammatory Bowel Diseases,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT07219537

Recruiting

Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease

for
Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT07456566

Recruiting

Evaluation of the SMART IBD App in Pediatric IBD

for
Inflammatory Bowel Disease (IBD),
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 13 - 17

Code: NCT07195123

Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Morehead City NC, Greenville NC, Wilmington NC,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase3, Recruiting

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

for
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced),
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12 - 70+

Code: NCT05398809

Phase2, Recruiting

Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis

for
IBD (Inflammatory Bowel Disease)
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07168499

Recruiting

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

for
Acute Myeloid Leukemia, Graft Versus Host Disease,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06996119

Phase1, Recruiting

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

for
Crohn Disease (CD), IBD (Inflammatory Bowel Disease),
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 9 - 17

Code: NCT07314606

Recruiting

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06815003

Phase2, Recruiting

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

for
Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC),
Location: Providence RI, New York NY, Raleigh NC, Rochester NY,
Sponsor: Mirador Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07113522

Phase2, Recruiting

BOOM-IBD2 Pivotal Clinical Trial

for
Ulcerative Colitis, Inflammatory Bowel Diseases
Location: Manhasset NY, New York NY, Chapel Hill NC, Columbia SC,
Sponsor: Boomerang Medical

Sex: All

Age: 18 - 70+

Code: NCT06571669

Recruiting